Nonphotic entrainment of the circadian body temperature rhythm by the selective ORL1 receptor agonist W-212393 in rats

British Journal of Pharmacology

Volumn 146, Issue 1, 2005, Pages 33-40

  Teshima, Koji ^a   Minoguchi, Masanori ^a   Tounai, Sayuri ^a   Ashimori, Atsuyuki ^a   Eguchi, Junichi ^a   Allen, Charles N ^b   Shibata, Shigenobu ^c  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c WASEDA UNIVERSITY   (Japan)

Author keywords

Circadian rhythm; Nociceptin; Nonphotic entrainment; ORL1; Orphanin FQ; SCN; W 212393

Indexed keywords

1 (1 CYCLOOCTYLMETHYL 3 HYDROXYMETHYL 4 PIPERIDYL) 3 ETHYL 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 2 [3 [1 (ACENAPHTHEN 1 YL) PIPERIDIN 4 YL] 2,3 DIHYDRO 2 OXO BENZIMIDAZOL 1 YL] N METHYLACETAMIDE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NOCICEPTIN; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; UNCLASSIFIED DRUG; W 212393;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; CELL STRAIN HEK293; CIRCADIAN RHYTHM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; LIGHT DARK CYCLE; MALE; NERVE CELL; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SUPRACHIASMATIC NUCLEUS;

ACENAPHTHENES; ACTION POTENTIALS; ANIMALS; BENZIMIDAZOLES; BINDING, COMPETITIVE; BODY TEMPERATURE; CELL LINE; CEREBRAL CORTEX; CIRCADIAN RHYTHM; HUMANS; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SUPRACHIASMATIC NUCLEUS;

EID: 28444485374     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706311     Document Type: Article

References (29)

1. ALLEN, C.N., JIANG, Z.G., TESHIMA, K., DARLAND, T., IKEDA, M., NELSON, C.S., QUIGLEY, D.I., YOSHIOKA, T., ALLEN, R.G., REA, M.A. & GRANDY, D.K. (1999). Orphanin-FQ/nociceptin (N/OFQ) modulates the activity of suprachiasmatic nucleus neurons. J. Neurosci., 19, 2152-2160.
2. BENLOUCIF, S. & DUBOCOVICH, M.L. (1996). Melatonin and light induce phase shifts of arcadian activity rhythms in the C3H/HeN mouse. J. Biol. Rhythms, 11, 113-125.
3. BUNZOW, J.R., SAEZ, C., MORTRUD, M., BOUVIER, C., WILLIAMS, J.T., LOW, M. & GRANDY, O.K. (1994). Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not m, d or k opioid receptor type. FEBS Lett., 347, 284-288.
4. CHIOU, L.-C, CHUANG, K.-C, WICHMANN, J. & ADAM, G. (2004). Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza- spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. J. Pharmacol. Exp. Ther., 311, 645-651.
5. CICCOCIOPPO, R., ECONOMIDOU, D., FEDELI, A., ANGELETTI, S., WEISS, F., HEILIG, M. & MASSI, M. (2004). Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berlin), 172, 170-178.
6. CICCOCIOPPO, R., ECONOMIDOU, D., FEDELI, A. & MASSI, M. (2003). The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats. Physiol. Behav., 79, 121-128.
7. COURTEK, C., COUDORE-CIVIALE, M.A., PRIVAT, A.M., PELISSIER, T., ESCHALIER, A. & FIALIP, J. (2004). Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain, 110, 236-245.
8. HONMA, S., SHIRAKAWA, T., KATSUNO, Y., NAMIHIRA, M. & HONMA, K. (1998). Circadian periods of single suprachiasmatic neurons in rats. Neurosci. Lett., 250, 157-160.
9. HORIKAWA, K. & SHIBATA, S. (2004). Phase-resetting response to (+)8-OH-DPAT, a serotonin 1 A/7 receptor agonist, in the mouse in vivo. Neurosci. Lett., 368, 130-134.
10. 2+ in single suprachiasmatic nucleus neurons. Neuron, 38, 253-263.
11. JENCK, F., MOREAU, J.L., MARTIN, J.R., KILPATRICK, G.J., REINSCHEID, R.K., MONSMA JR, F.J., NOTHACKER, H.P. & CIVELLI, O. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U.S.A., 94, 14854-14858.
12. JENCK, F., WICHMANN, J., DAUTZENBERG, F.M., MOREAU, J.L., OUAGAZZAL, A.M., MARTIN, J.R., LUNDSTROM, K., CESURA, A.M., POLI, S.M., ROEVER, S., KOLCZEWSKI, S., ADAM, G. & KILPATRICK, G. (2000). A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. U.S.A., 97, 4938-4943.
13. JIANG, Z.-G., NELSON, C.S. & ALLEN, C.N. (1995). Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons. Brain Res., 687, 125-132.
14. JIANG, Z.-G., TESHIMA, K., YANG, Y., YOSHIOKA, T. & ALLEN, C.N. (2000). Pre- and postsynaptic actions of serotonin on rat suprachiasmatic nucleus neurons. Brain Res., 866, 247-256.
15. KO, M.C.H., NAUGHTON, N.N., TRAYNOR, J.R., SONG, M.S., WOODS, J.H., RICE, K.C. & MCKNIGHT, A.T. (2002). Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors. Br. J. Pharmacol., 135, 943-950.
16. KUZMIN, A., SANDIN, J., TERENIUS, L. & OGREN, S.O. (2003). Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther., 304, 310-318.
17. KUZMIN, A., SANDIN, J., TERENIUS, L. & OGREN, S.O. (2004). Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. Br. J. Pharmacol., 141, 132-140.
18. MAYWOOD, E.S., MROSOVSKY, N., FIELD, M.D. & HASTING, M.H. (1999). Rapid down-regulation of mammalian Period genes during behavioral resetting of the circadian clock. Proc. Natl. Acad. Sci. U.S.A., 96, 15211-15216.
19. 1 receptor. Nature, 377, 532-535.
20. MOGIL, J.S. & PASTERNAK, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev., 53, 381-415.
21. MOLLEREAU, C., PARMENTIER, M., MAILLEUX, P., BUTOUR, J.L., MOISAND, C., CHALON, P., CAPUT, D., VASSART, G. & MEUNIER, J.C. (1994). ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett., 341, 33-38.
22. OZAKI, S., KAWAMOTO, H., ITOH, Y., MIYAJI, M., IWASAWA, Y. & OHTA, H. (2000). A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397. Eur. J. Pharmacol., 387, R17-R18.
23. POMONIS, J.D., BILLINGTON, C.J. & LEVINE, A.S. (1996). Orphanin FQ, agonist of orphan opioid receptor ORLl, stimulates feeding in rats. Neuroreport, 8, 369-371.
24. REDMAN, J., ARMSTRONG, S. & NG, K.T. (1983). Free-running activity rhythms in the rat: entrainment by melatonin. Science, 219, 1089-1091.
25. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J.R., GRANDY, D.K., LANGEN, H., MONSMA JR, F.J. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794.
26. SACK, R.L., LEWY, A.J., BLOOD, M.L., STEVENSON, J. & KEITH, L.D. (1991). Melatonin administration to blind people: phase advances and entrainment. J. Biol. Rhythms, 6, 249-261.
27. SAKOORI, K. & MURPHY, N.P. (2004). Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berlin), 172, 129-136.
28. SANDIN, J., GEORGIEVA, J., SCHOTT, P.A., OGREN, S.O. & TERENIUS, L. (1997). Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci., 9, 194-197.
29. TOMINAGA, K., SHIBATA, S., UEKI, S. & WATANABE, S. (1992). Effects of 5-HT1A receptor agonists on the circadian rhythm of wheel-running activity in hamsters. Eur. J. Pharmacol., 214, 79-84.